EDGAR Filing Documents for 0001047469-17-007229

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001047469-17-007229

Filing Date

2017-11-21

Accepted

2017-11-21 15:16:21

Documents

Period of Report

2017-12-19

Effectiveness Date

2017-11-21

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	a2233861zdef14a.htm	DEF 14A	566879
2	G252312BCI001.JPG	g252312bci001.jpg	GRAPHIC	127889
3	G252312BCI002.JPG	g252312bci002.jpg	GRAPHIC	70952
4	G16428.JPG	g16428.jpg	GRAPHIC	15608
5	G506285.JPG	g506285.jpg	GRAPHIC	5658
6	G947703.JPG	g947703.jpg	GRAPHIC	9740
	Complete submission text file	0001047469-17-007229.txt		885123

Mailing Address 2800 Patton Rd St Paul MN 55113

Business Address 2800 Patton Rd St Paul MN 55113 651-634-3003

ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33818 | Film No.: 171216647
SIC: 3845 Electromedical & Electrotherapeutic Apparatus